Evidence map›Paper›PMID 30876468›Full record

ArticleBMC cancer2019

Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors.

Hilde Ytre-Hauge Smeland, Ning Lu, Tine V Karlsen, Gerd Salvesen, Rolf K Reed, Linda Stuhr

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. 3D bioprinting innovations: a new frontier in breast cancer research.Medical oncology (Northwood, London, England) · 2025
    Review
  4. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hilde Ytre-Hauge SmelandDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway. hilde.smeland@uib.no.ORCID http://orcid.org/0000-0001-5607-6416
Ning LuDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
Tine V KarlsenDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
Gerd SalvesenDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
Rolf K ReedDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
Linda StuhrDepartment of Biomedicine, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.
NORCE Research AS · NOUniversity of Bergen · NO

Funding

Norges Forskningsråd 223250
6 · The paper itself

Abstract

backgroundCancer progression is influenced by a pro-tumorigenic microenvironment. The aberrant tumor stroma with increased collagen deposition, contractile fibroblasts and dysfunctional vessels has a major impact on the interstitial fluid pressure (PIF) in most solid tumors. An increased tumor PIF is a barrier to the transport of interstitial fluid into and within the tumor. Therefore, understanding the mechanisms that regulate pressure homeostasis can lead to new insight into breast tumor progression, invasion and response to therapy. The collagen binding integrin α11β1 is upregulated during myofibroblast differentiation and expressed on fibroblasts in the tumor stroma. As a collagen organizer and a probable link between contractile fibroblasts and the complex collagen network in tumors, integrin α11β1 could be a potential regulator of tumor PIF.

methodsWe investigated the effect of stromal integrin α11-deficiency on pressure homeostasis, collagen organization and tumor growth using orthotopic and ectopic triple-negative breast cancer xenografts (MDA-MB-231 and MDA-MB-468) in wild type and integrin α11-deficient mice. PIF was measured by the wick-in-needle technique, collagen by Picrosirius Red staining and electron microscopy, and uptake of radioactively labeled 5FU by microdialysis. Further, PIF in heterospheroids composed of MDA-MB-231 cells and wild type or integrin α11-deficient fibroblasts was measured by micropuncture.

resultsStromal integrin α11-deficiency decreased PIF in both the orthotopic breast cancer models. A concomitant perturbed collagen structure was seen, with fewer aligned and thinner fibrils. Integrin α11-deficiency also impeded MDA-MB-231 breast tumor growth, but no effect was observed on drug uptake. No effects were seen in the ectopic model. By investigating the isolated effect of integrin α11-positive fibroblasts on MDA-MB-231 cells in vitro, we provide evidence that PIF regulation was mediated by integrin α11-positive fibroblasts.

conclusionWe hereby show the importance of integrin α11β1 in pressure homeostasis in triple-negative breast tumors, indicating a new role for integrin α11β1 in the tumor microenvironment. Our data suggest that integrin α11β1 has a pro-tumorigenic effect on triple-negative breast cancer growth in vivo. The significance of the local microenvironment is shown by the different effects of integrin α11β1 in the orthotopic and ectopic models, underlining the importance of choosing an appropriate preclinical model.

Indexed as

AnimalsCell Line, TumorCollagenCytoprotectionExtracellular FluidFemaleGene Knockout TechniquesHumansIntegrin alpha ChainsIntegrinsMiceNeoplasm TransplantationReceptors, CollagenStromal CellsTriple Negative Breast NeoplasmsTumor MicroenvironmentCollagenintegrin alpha11beta1integrin alpha11, mouseIntegrin alpha ChainsIntegrinsReceptors, CollagenCancer associated fibroblastsCollagen organizationIntegrin α11β1Interstitial fluid pressureTriple-negative breast cancer

Identifiers

PMID30876468
PMCPMC6419843
OpenAlexW2940408530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.